Delivery Order SPE2DR25D9231-SPE2DR26FHNN8
- Not listed
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in 1-dose vial formulations. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. on October 23, 2025, for YF-VAX (yellow fever vaccine) in one-dose vials to be delivered to Park Ridge, Illinois, with completion by November 14, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. The award reflects the company's...
- The Defense Logistics Agency awarded a delivery order valued at $22,270.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on October 27, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. No set-aside designation was utilized in this competitive procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $36,196.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (Yellow Fever Vaccine) 1 dose vials on October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract with an ultimate completion date of November 21, 2025. This delivery order was issued without a set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The contract utilizes firm fixed-price pricing with an ultimate completion date of November 13, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- SPE2DR25D9231Indefinite Delivery Contract
- SPE2DR25D9231-SPE2DR26FHNN8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted procurement environment. DMS Pharmaceutical Group Inc. will perform this work at its Park Ridge, Illinois location. This delivery order was issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That umbrella contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue multiple delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V represents part of a broader $30.3 billion federal acquisition strategy, with DMS Pharmaceutical Group established as one of multiple regional prime vendor contractors positioned to supply critical pharmaceutical requirements for military healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/3/25 |